- Home
- RWAY vs BME Comparison
RWAY vs BME Comparison
Compare RWAY & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWAY
- BME
- Stock Information
- Founded
- RWAY 2015
- BME 2005
- Country
- RWAY United States
- BME United States
- Employees
- RWAY N/A
- BME N/A
- Industry
- RWAY
- BME Trusts Except Educational Religious and Charitable
- Sector
- RWAY
- BME Finance
- Exchange
- RWAY Nasdaq
- BME Nasdaq
- Market Cap
- RWAY 410.4M
- BME 474.7M
- IPO Year
- RWAY 2021
- BME N/A
- Fundamental
- Price
- RWAY $10.23
- BME $36.41
- Analyst Decision
- RWAY Buy
- BME
- Analyst Count
- RWAY 6
- BME 0
- Target Price
- RWAY $11.00
- BME N/A
- AVG Volume (30 Days)
- RWAY 217.5K
- BME 34.0K
- Earning Date
- RWAY 11-11-2025
- BME 01-01-0001
- Dividend Yield
- RWAY 13.70%
- BME 6.26%
- EPS Growth
- RWAY 153.06
- BME N/A
- EPS
- RWAY 1.91
- BME 1.44
- Revenue
- RWAY $140,975,000.00
- BME N/A
- Revenue This Year
- RWAY N/A
- BME N/A
- Revenue Next Year
- RWAY N/A
- BME N/A
- P/E Ratio
- RWAY $5.34
- BME $28.37
- Revenue Growth
- RWAY N/A
- BME N/A
- 52 Week Low
- RWAY $8.35
- BME $35.53
- 52 Week High
- RWAY $11.73
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- RWAY 32.39
- BME 45.05
- Support Level
- RWAY $10.60
- BME $37.03
- Resistance Level
- RWAY $10.92
- BME $37.58
- Average True Range (ATR)
- RWAY 0.15
- BME 0.32
- MACD
- RWAY -0.05
- BME -0.06
- Stochastic Oscillator
- RWAY 7.38
- BME 5.64
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.